Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 6/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27651191 | 0.90 | TDP1 (0.40) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL11458719 | 0.86 | ALDH1A1 (0.52) | TDP1CA2TSHRCYP3A4ALDH1A1 | |
| SCHEMBL3424586 | 0.85 | TDP1 (0.50) | TDP1ADRA1ACA2ALDH1A1 | |
| SCHEMBL6860417 | 0.85 | CA2 (0.46) | TDP1CA2TSHRCYP3A4ALDH1A1 | |
| SCHEMBL20838328 | 0.84 | CA2 (0.39) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| Hydrochloric Acid SCHEMBL6139371 | 0.82 | TDP1 (0.47) | TDP1CA2ALDH1A1 | |
| SCHEMBL11469777 | 0.82 | FAAH (0.35) | TDP1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL6861932 | 0.80 | LMNA (0.45) | CA2CA1FDPS | |
| Hypochlorous Acid SCHEMBL6139372 | 0.80 | TDP1 (0.45) | TDP1CA2TSHRALDH1A1 | |
| SCHEMBL20838318 | 0.79 | CA2 (0.48) | TDP1CHRM1AKR1A1CHRM3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12222653-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-02-11 | — | — | US | disclosed |
| US-20210286269-A1 | METHOD FOR FORMING SEMICONDUCTOR STRUCTURE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2021-09-16 | — | — | US | disclosed |
| US-20210286269-A1 | METHOD FOR FORMING SEMICONDUCTOR STRUCTURE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2021-09-16 | — | — | US | disclosed |
| US-11009796-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-05-18 | — | — | US | disclosed |
| US-11009796-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-05-18 | — | — | US | disclosed |
| US-10990013-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-04-27 | — | — | US | disclosed |
| US-10990013-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-04-27 | — | — | US | disclosed |
| US-10838304-B2 | Priming material for organometallic resist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2020-11-17 | — | — | US | disclosed |
| CN-110828302-A | Film forming method | 台湾积体电路制造股份有限公司 | 2020-02-21 | — | — | CN | disclosed |
| US-20200050109-A1 | Priming Material for Organometallic Resist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2020-02-13 | — | — | US | disclosed |
| US-20190096675-A1 | METHOD FOR FORMING SEMICONDUCTOR STRUCTURE | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2019-03-28 | — | — | US | disclosed |
| US-20190096675-A1 | METHOD FOR FORMING SEMICONDUCTOR STRUCTURE | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2019-03-28 | — | — | US | disclosed |
| US-7365209-B2 | Nitrogen heterocycle biaryls for osteoporosis and other diseases | PHARMACOPEIA, INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-20050222203-A1 | [4(2-methylamino-3-methyl)benzimidazol]1-[(4-carboxyethylamido-2,5-dimethyloxy)phenyl]ester; vitronectin receptor antagonist; endometriosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity; disruption of osteoclast adhesion | PHARMACOPEIA, INC. (US) | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222203-A1 | [4(2-methylamino-3-methyl)benzimidazol]1-[(4-carboxyethylamido-2,5-dimethyloxy)phenyl]ester; vitronectin receptor antagonist; endometriosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity; disruption of osteoclast adhesion | MSR1, EDNRA, GPR174 | TDP1 3850/4885CHRM1 738/4885AKR1A1 1158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.